Rubra Medicaments informs about quarterly statement on investor complaints

04 Apr 2016 Evaluate

Rubra Medicaments has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Rubra Medicaments Share Price

9.41 -0.24 (-2.49%)
16-May-2024 14:46 View Price Chart
Peers
Company Name CMP
Adani Enterprises 3042.00
Redington 214.50
Amrapali Industries 14.85
Rashi Peripheral 328.00
Compuage Infocom 4.36
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.